| CHI’s Adopting R&D Informatics Systems | |
|
United States - CA - San Francisco |
|
| Hosted by: | Cambridge Healthtech Institute |
| Venue: | Moscone North Convention Center |
| Dates: | Feb 03, 2010 through Feb 05, 2010 |
| Call for Posters: | 2009-01-01 through 2009-12-23 |
| Event Registration: | 2009-10-01 through 2010-02-03 |
| Early Registration Deadline: | 2009-11-23 |
|
Description |
|
| Part of CHI’s 17th International Molecular Medicine Tri-Conference... The ONLY conference that will bring together a unique mix of delegates from both Pharmaceutical and Biotech IT, research informatics groups and those involved with knowledge management, translational informatics and computational science for one purpose: to further the adoption of integrated R&D informatic systems and accelerate drug discovery. Just a Few Program Highlights: * Special talks on the use of open source and public platforms to drive drug discovery from Pfizer, Eli Lilly, and Gilead. * The ONLY conference to feature recent strategies with cloud, wikis, ontologies, open data standards and the semantic web. * Panel discussion on "Drug Discovery Collaborations in 2010" moderated by Barry A. Bunin, Ph.D. of Collaborative Drug Discovery (CDDI), Inc. * Pre-conference Short Course on "Best Practices in Translational & Personalized Medicine"* * Network with 3,000+ delegates in our plenary keynote sessions, luncheons, breaks, cocktail receptions, poster sessions, etc. * Educate yourself with the latest technologies and services in our exhibit hall and meet Accelrys, Applied Biosystems, Evotec, Microsoft, and NanoString Technologies, to name a few. |
|
| Additional Information | |
| Event URL: | http://www.tri-conference.com/ird.asp |
| ISCB Member Discount: | None |
| Contact Person: | James Prudhomme ([javascript protected email address]) |
While ISCB provides for conference and event listings that may be of interest to members and bioinformaticians at large, ISCB is not responsible for the content provided by outside sources. Such listings are not meant as an endorsement by ISCB.
